Michael D Step
CIK 1316386 · CEO · last filed 2018-01-25
Michael D Step is a CEO who has filed 22 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for RTTR, was dated Jan 25, 2018. Across all open-market trades the lifetime net is −$2.3M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SNTS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN DIEGO, CA 92130
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Qualigen Therapeutics, Inc. (RTTR) Delisted | CEO | 308 | — | — | $74.4K | 7 | 2018-01-25 |
| SANTARUS INC (SNTS) Delisted | SVP, Corporate Development | 1,497 | — | — | -$2.40M | 14 | 2013-09-06 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| RTTR | Direct | 108 | 35.1% | 2016-01-08 |
| By Michael D. Step Family Trust | 200 | 64.9% | 2017-05-12 | |
| Total | 308 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-25 | Qualigen Therapeutics, Inc. (RTTR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-12 | Qualigen Therapeutics, Inc. (RTTR) Delisted | Buy (P) | +13,000 | $8.0K | EDGAR |
| 2017-02-28 | Qualigen Therapeutics, Inc. (RTTR) Delisted | Buy (P) | +10,000 | $26.5K | EDGAR |
| 2017-01-27 | Qualigen Therapeutics, Inc. (RTTR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-07-07 | Qualigen Therapeutics, Inc. (RTTR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-08 | Qualigen Therapeutics, Inc. (RTTR) Delisted | Buy (P) | +27,000 | $40.0K | EDGAR |
| 2015-08-31 | Qualigen Therapeutics, Inc. (RTTR) Delisted | — | — | $0 | EDGAR |
| 2014-01-06 | — | Mixed | −2,225 | -$4.24M | |
| 2013-09-06 | SANTARUS INC (SNTS) Delisted | Mixed | — | -$666.4K | EDGAR |
| 2013-07-08 | SANTARUS INC (SNTS) Delisted | Mixed | — | -$623.7K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).